Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Ermenegildo Zegna NV
ZGN
DexCom
DXCM
Workday
WDAY
US Stock MarketDetailed Quotes
NCNA NuCana
- 1.1300
- +0.0300+2.73%
Close Jan 24 16:00 ET
- 1.1600
- +0.0300+2.65%
Post 20:01 ET
4.44MMarket Cap-0.08P/E (TTM)
1.1400High1.0799Low52.81KVolume1.1100Open1.1000Pre Close58.91KTurnover1.56%Turnover RatioLossP/E (Static)3.93MShares19.410052wk High0.83P/B3.82MFloat Cap0.960152wk Low--Dividend TTM3.38MShs Float800.0000Historical High--Div YieldTTM5.46%Amplitude0.9601Historical Low1.1150Avg Price1Lot Size
About NuCana Company
NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
Company Profile
SymbolNCNA
Company NameNuCana
Listing DateSep 28, 2017
Issue Price15.00
Founded1997
CEOMr. Hugh S. Griffith
MarketNASDAQ
Employees28
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address3 Lochside Way
CityEdinburgh
ProvinceMidlothian
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeEH12 9DT
Phone44-131-357-1111
Websitehttp://www.nucana.com
Company Executives
- Name
- Position
- Salary
- Hugh S. Griffith
- Chief Executive Officer and Director
- 974.59K
- Jeffrey Bloss, M.D.
- Chief Medical Officer
- --
- Donald Munoz
- Chief Financial Officer
- --
- Andrew Kay
- Non-Executive Chairman of the Board
- 78.77K
- Cyrille Leperlier, M.D.
- Independent Director
- 65.08K
- Dr. Bali Muralidhar, M.D.,PhD
- Independent Director
- --
- Adam George
- Independent Director
- 56.56K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 54.23K
- Martin Christopher Bagot Mellish
- Independent Director
- 47.85K
- David Harrison, M.D.
- Head, Translational Studies
- --